Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2013

Dec 5, 2013

35274_dirs_2013-12-05_aeac25ea-4646-450f-b5ef-2924942a97e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2013-12-05

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-05 Common Stock G 4000 Disposed 680994 Direct

Footnotes

F1: N/A